2-Chlorosulfonyl methyl benzoate
CAS : 26638-43-7
Ref. 3D-FC12436
2g | Arrêté | ||
5g | Arrêté | ||
10g | Arrêté | ||
25g | Arrêté | ||
50g | Arrêté |
Informations sur le produit
- 2-(Carbomethoxy)benzenesulfonyl chloride
- 2-(Chlorosulfonyl)-Benzoicacimethylester
- 2-(Chlorosulfonyl)Benzoic Acid Methyl Ester
- 2-(Methoxycarbonyl)benzenesulfonyl chloride
- 2-Carbomethoxybenzenesulfonyl Chloride
- 2-Chlorosulfonylbenzoic acid methyl ester
- 2-Methoxycarbonylbenzenesulfonyl Chloride
- Benzoic acid, 2-(chlorosulfonyl)-, methyl ester
- Benzoic acid, o-(chlorosulfonyl)-, methyl ester
- Methyl-O-(Chlorosulfonyl)Benzoate
- Voir d'autres synonymes
- O-Carbomethoxybenzenesulfonylchloride
- o-(Carbomethoxy)benzenesulfonyl chloride
- o-(Methoxycarbonyl)benzenesulfonyl chloride
2-Chlorosulfonyl methyl benzoate (2CSMB) is a sulfonamide that has been synthesized. It is an inhibitor of carbonic anhydrase and can be used for the treatment of glaucoma. 2CSMB has been shown to be effective in the g1 phase of the cell cycle, and its mechanism of action may be due to inhibition of the enzyme carbonic anhydrase by binding to its active site. The molecular modelling studies have been carried out using computer simulation techniques which predict the 3D structure of 2CSMB bound to carbonic anhydrase.